Please login to the form below

Not currently logged in
Email:
Password:

HeartCel

This page shows the latest HeartCel news and features for those working in and with pharma, biotech and healthcare.

Celixir cleared to start trial of stem cell therapy for heart failure

Celixir cleared to start trial of stem cell therapy for heart failure

Previous trial demonstrated patients achieving 100% MACE free survival. UK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel - its stem cell-based therapy ... The initial Heartcel trial results are very exciting, showing

Latest news

  • Cell Therapy licenses heart failure therapy in Japan Cell Therapy licenses heart failure therapy in Japan

    Additional undisclosed payments will also be forthcoming if HeartCel passes other development and regulatory milestones, as well as royalties on any future sales. ... HeartCel has been clinically tested with heart failure patients who undergo bypass

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics